Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 2:22 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Consonance Capital Management LP | 6,058,505 11.000% |
3,169,617 (+109.72%) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | Omeros Corporation OMER |
Consonance Capital Management LP | 6,058,505 11.000% |
2,862,709 (+89.58%) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | Liminal BioSciences Inc. LMNL |
Consonance Capital Management LP | 605,851 11.000% |
277,119 (+84.30%) |
Filing History |
| 2021-02-16 2:21 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Consonance Capital Management LP | 403,900 11.000% |
-4,595 (-1.12%) |
Filing History |
| 2021-02-16 2:21 pm Sale |
2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN |
Consonance Capital Management LP | 6,834,770 9.990% |
-8,807,294 (-56.31%) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
Consonance Capital Management LP | 6,058,505 9.990% |
2,632,140 (+76.82%) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | GENMARK DIAGNOSTICS INC GNMK |
Consonance Capital Management LP | 6,058,505 9.990% |
6,058,505 (New Position) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | GAMIDA CELL LTD GMDAQ |
Consonance Capital Management LP | 6,058,505 9.990% |
6,058,505 (New Position) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU |
Consonance Capital Management LP | 6,058,505 9.990% |
4,624,505 (+322.49%) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 605,851 9.990% |
605,851 (New Position) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
Consonance Capital Management LP | 605,851 9.990% |
605,851 (New Position) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | CareDx, Inc CDNA |
Consonance Capital Management LP | 6,058,505 11.000% |
3,936,529 (+185.51%) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | AxoGen, Inc. AXGN |
Consonance Capital Management LP | 6,058,505 11.000% |
3,072,119 (+102.87%) |
Filing History |
| 2021-02-16 2:19 pm Sale |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Consonance Capital Management LP | 6,058,505 11.000% |
-567,166 (-8.56%) |
Filing History |
| 2021-02-16 2:19 pm Sale |
2020-12-31 | 13G | ARQULE INC ARQL |
Consonance Capital Management LP | 6,058,505 11.000% |
-679,701 (-10.09%) |
Filing History |
| 2021-02-16 2:11 pm Sale |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Consonance Capital Management LP | 1,558,290 1.650% |
-3,608,671 (-69.84%) |
Filing History |
| 2020-12-03 1:40 pm Purchase |
2020-11-23 | 13D | CONSONANCE-HFW ACQUISITION COR CHFWU |
Consonance Capital Management LP | 1,434,000 14.900% |
1,434,000 (New Position) |
Filing History |
| 2020-11-05 4:55 pm Sale |
2020-10-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Consonance Capital Management LP | 1,252,229 3.990% |
-988,550 (-44.12%) |
Filing History |
| 2020-06-16 09:37 am Purchase |
2020-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Consonance Capital Management LP | 2,240,779 11.000% |
2,240,779 (New Position) |
Filing History |